tirzepatide vs semaglutide dosing comparison For Weight Loss (2026): Which Works Better? The recommended dosing schedule for

20% Average Weight Loss People using Mounjaro & Zepbound, medications with the active ingredient tirzepatide, lost 20% of their body weight on average

Tirzepatide is an FDA-approved prescription once-weekly injection medication that you self-inject into your stomach, front of the thigh, or back of the upper arm

Injecting Mounjaro should never be very painful

GI side effects usually stabilize during this phase

Microdosing considerations Some researchers use tirzepatide microdosing protocols that involve doses below the standard 2.5 mg starting point

ANALYSIS OF THE PATENT LANDSCAPE FOR SEMAGLUTIDE AND TIRZEPATIDE This section examines the patent thicket that Novo Nordisk and Eli Lilly have built around the drugs Ozempic, Rybelsus and Wegovy (semaglutide) and Mounjaro and Zepbound (tirzepatide)